$CVRX 3 SEC Filings

Filed On	Filing
03 Jun 2026	Form 3: Dale Michael D, Director No securities owned
04 Mar 2026	Form 3: Morrison Gregory, CHIEF HUMAN RESOURCES OFFICER No securities owned
13 Aug 2025	Form 3: Binkowski Brent, CHIEF OPERATING OFFICER No securities owned
14 Feb 2025	Form 3: Adamson Philip B., Chief Medical Officer
05 Sep 2024	Form 3: Hill, Mitch C., Director No securities owned
05 Sep 2024	Form 3: Ballinger Kevin J., Director No securities owned
01 Jul 2024	Form 3: John Robert Allen, Chief Revenue Officer No securities owned
18 Sep 2023	Form 3: Johnson & Johnson Innovation - JJDC, Inc., 10% owner Holds 3,495,575 shares of Common Stock
23 Dec 2022	Form 3: Hykes Kevin, Director No securities owned
28 Jan 2022	Form 3: Palmer Craig E., SVP, U.S. Sales
14 Jul 2021	Form 3: Shadan Martha, Director No securities owned
06 Jul 2021	Form 3: Glaxosmithkline Plc, 10% owner
29 Jun 2021	Form 3: Johnson & Johnson, 10% owner and 1 other
29 Jun 2021	Form 3: Behbahani Ali, Director
29 Jun 2021	Form 3: Nea Partners 10 L P, 10% owner and 1 other Holds 1,384 shares of Common Stock
29 Jun 2021	Form 3: New Enterprise Associates 10 L P, 10% owner
29 Jun 2021	Form 3: Nehra John M, Director Holds 489 shares of Common Stock
29 Jun 2021	Form 3: Pardo Geoffrey B, Director
29 Jun 2021	Form 3: Nielsen Kirk G., Director
29 Jun 2021	Form 3: Slattery Joseph P, Director

Comments